James J. Collins's Net Worth
$0
Who is James J. Collins?
James J. Collins does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., Orion Biotech Opportunities Corp., and Senti Biosciences, Inc..
SEC CIK
James J. Collins's CIK is 0001779269
Past Insider Trading and Trends
2022 was James J. Collins's most active year for acquiring shares with 2 total transactions. James J. Collins's most active month to acquire stocks was the month of May. 2023 was James J. Collins's most active year for disposing of shares, totalling 1 transactions. James J. Collins's most active month to dispose stocks was the month of April. 2022 saw James J. Collins paying a total of $0.00 for 144,000 shares, this is the most they've acquired in one year. In 2023 James J. Collins cashed out on 40,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Orion Biotech Opportunities Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Senti Biosciences, Inc. (SNTI) Snapshot price: $2.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |